
Sean Lee CFA
Stock Analyst at H.C. Wainwright
(0.25)
# 4,631
Out of 5,152 analysts
277
Total ratings
28.4%
Success rate
-5.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNSY Cerenome | Reiterated: Buy | $25 → $7 | $0.7068 | +890.38% | 29 | Nov 18, 2026 | |
| AKTX Akari Therapeutics, | Reiterated: Buy | $27 | $6.65 | +306.02% | 8 | Nov 16, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $24 → $20 | $7.06 | +183.29% | 33 | Nov 13, 2026 | |
| CRVS Corvus Pharmaceuticals | Reiterated: Buy | $27 | $10.19 | +164.97% | 11 | Nov 11, 2026 | |
| MYO Myomo | Reiterated: Buy | $5 | $0.88 | +468.18% | 11 | Nov 10, 2026 | |
| SENS Senseonics Holdings | Reiterated: Buy | $14 | $9.74 | +43.74% | 12 | Nov 10, 2026 | |
| DWTX Dogwood Therapeutics | Reiterated: Buy | $12 | $1.08 | +1,011.11% | 30 | Nov 6, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $18 | $5.49 | +227.87% | 13 | Oct 1, 2026 | |
| CTSO Cytosorbents | Reiterated: Hold | $15 | $5.57 | +169.54% | 31 | Aug 7, 2026 | |
| NVAX Novavax | Reiterated: Buy | $16 | $7.96 | +101.01% | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.10 | +3,900.00% | 20 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.87 | n/a | 35 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 | €1.46 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.03 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $70.75 | n/a | 18 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Mar 21, 2025 |
Cerenome
Nov 18, 2026
Reiterated: Buy
Price Target: $25 → $7
Current: $0.7068
Upside: +890.38%
Akari Therapeutics,
Nov 16, 2026
Reiterated: Buy
Price Target: $27
Current: $6.65
Upside: +306.02%
Alphatec Holdings
Nov 13, 2026
Reiterated: Buy
Price Target: $24 → $20
Current: $7.06
Upside: +183.29%
Corvus Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $27
Current: $10.19
Upside: +164.97%
Myomo
Nov 10, 2026
Reiterated: Buy
Price Target: $5
Current: $0.88
Upside: +468.18%
Senseonics Holdings
Nov 10, 2026
Reiterated: Buy
Price Target: $14
Current: $9.74
Upside: +43.74%
Dogwood Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $12
Current: $1.08
Upside: +1,011.11%
Kazia Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $18
Current: $5.49
Upside: +227.87%
Cytosorbents
Aug 7, 2026
Reiterated: Hold
Price Target: $15
Current: $5.57
Upside: +169.54%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $7.96
Upside: +101.01%
Dec 9, 2025
Reiterated: Buy
Price Target: $4
Current: $0.10
Upside: +3,900.00%
Nov 5, 2025
Reiterated: Buy
Price Target: $14
Current: $6.87
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: €14.00
Current: €1.46
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $11
Current: $1.03
Upside: n/a
Apr 1, 2025
Reiterated: Buy
Price Target: $40
Current: $70.75
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a